$TGTX News TG Therapeutics (TGTX) Worth Watching: Stock

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
$TGTX News

TG Therapeutics (TGTX) Worth Watching: Stock Up 9.1% - Tale of the Tape 8:44 a.m. Today - Zacks.com
Ligand Up on Multi-Program Captisol Deal with Avion Pharma - Analyst Blog 5:10 p.m. Aug. 18, 2014 - Zacks.com
Falling Earnings Estimates Signal Weakness Ahead for TG Therapeutics (TGTX) - Tale of the Tape 8:27 a.m. Aug. 8, 2014 - Zacks.com
Ligand: Pipeline Breakdown Reveals Bullish Outlook 9:12 a.m. July 30, 2014 - Seeking Alpha
10-Q: TG THERAPEUTICS, INC. 4:38 p.m. July 24, 2014 - Edgar Online - (EDG = 10Q, 10K)
TG Therapeutics' (TGTX) CEO Mike Weiss on Q2 2014 Results - Earnings Call Transcript 2:56 p.m. July 22, 2014 - Seeking Alpha
TG Therapeutics (TGTX) in Focus: Stock Moves 10.4% Higher - Tale of the Tape 9:25 a.m. July 3, 2014 - Zacks.com
Ligand Pharma-TG Therapeutics Collaborate on IRAK4 Inhibitors - Analyst Blog 4:30 p.m. June 25, 2014 - Zacks.com
TG Therapeutics (TGTX) is Overbought: Is A Drop Coming? - Tale of the Tape 9:19 a.m. June 25, 2014 - Zacks.com
Strength Seen in TG Therapeutics, Inc. (TGTX) as Stock Rallies 12.94% - Tale of the Tape 8:44 a.m. June 24, 2014 - Zacks.com
A new partnership to develop IRAK-4 inhibitors 7:41 a.m. June 24, 2014 - Seeking Alpha
TG Therapeutics (TGTX) Crumbles: Stock Falls by 6.6% - Tale of the Tape 8:41 a.m. June 19, 2014 - Zacks.com
TG Therapeutics (TGTX) Catches Eye: Stock Surges 20.8% in Session - Tale of the Tape 8:37 a.m. June 13, 2014 - Zacks.com
Interim Phase 2 results for TG Therapeutics' cancer mAb 7:48 a.m. June 13, 2014 - Seeking Alpha
Bullish chart action for TG Therapeutics 5:23 p.m. June 12, 2014 - Seeking Alpha
Market Crash in the Cards? 3 Stocks to Book Profits - Investment Ideas 4:06 a.m. June 4, 2014 - Zacks.com
TG Therapeutics' (TGTX) CEO Michael Weiss on Q1 2014 Results - Earnings Call Transcript 1:31 p.m. May 13, 2014 - Seeking Alpha
The Recent Performance of 'Baker Brother Biotech Stocks' is Awful 12:23 p.m. April 15, 2014 - TheStreet.com
TG Therapeutics Gets A Triple Thumbs Up From The Baker Brothers 11:23 a.m. March 13, 2014 - Seeking Alpha
TG Therapeutics (TGTX) is Overbought, What's Next? - Tale of the Tape 9:35 a.m. March 13, 2014 - Zacks.com


TG Therapeutics Announces Novel "Chemo-free" Triple Therapy Combination Clinical Study for Patients With Chronic Lymphocytic Leukemia and Other B-cell Malignancies 7:30 a.m. Aug. 15, 2014 - GlobeNewswire
TG Therapeutics' Novel Combination of TG-1101 (Ublituximab) and TGR-1202 Demonstrates Compelling Early Activity and Safety Profile in Patients With Previously Treated High-Risk Chronic Lymphocytic Leukemia (CLL) and Aggressive Lymphomas 4:06 p.m. July 21, 2014 - GlobeNewswire
TG Therapeutics, Inc. Announces Second Quarter 2014 Financial Results and Business Update 4:06 p.m. July 21, 2014 - GlobeNewswire
Global Pharmaceutical Survey 2013-2014 - Market Trends, Buyer Spend and Procurement Strategies in the Global Pharmaceutical Industry 4:27 p.m. July 15, 2014 - PR Newswire - PRF
Technical Updates, License Agreements, and Acquisitions - Analyst Notes on Incyte, BioMarin, Arrowhead, Ligand and Techne 5:50 a.m. July 8, 2014 - PR Newswire - PRF
Divestitures, Agreement for Developmental Rights, Data Presentations, Technical Update, and Licensing Agreements - Analyst Notes on Akorn, Merrimack, Avanir, Omeros and TG Therapeutics 6:40 a.m. June 27, 2014 - PR Newswire - PRF
TG Therapeutics Completes Global Licensing Agreement With Ligand Pharmaceuticals for the Development of Inhibitors of IRAK4 8:09 a.m. June 24, 2014 - GlobeNewswire
Ligand Signs Global License Agreement with TG Therapeutics for IRAK-4 Inhibitor Program 3:01 a.m. June 24, 2014 - BusinessWire - BZX
TG Therapeutics, Inc. to Present at the 2014 JMP Securities Healthcare Conference 8:31 a.m. June 23, 2014 - GlobeNewswire
Sales, Clinical Hold Removal, Trial Initiations, and Committee Recommendations - Analyst Notes on Geron, Zalicus, Northwest Biotherapeutics, Progenics and TG Therapeutics 5:30 a.m. June 17, 2014 - PR Newswire - PRF
TG Therapeutics, Inc. to Present at the 2014 Wells Fargo Healthcare Conference 4:30 p.m. June 16, 2014 - GlobeNewswire
TG Therapeutics' TG-1101 (Ublituximab) in Combination With Ibrutinib Demonstrates Compelling Clinical Activity and Safety Profile in Patients With Previously Treated Chronic Lymphocytic Leukemia (CLL) and Mantle Cell Lymphoma (MCL) 5:31 a.m. June 13, 2014 - GlobeNewswire
Coronado Biosciences Announces February Inducement Award 4:06 p.m. May 9, 2014 - GlobeNewswire
TG Therapeutics, Inc. Provides Update on a Modified TGR-1202 Formulation and Fed-State Dosing With Data Demonstrating Significantly Higher TGR-1202 Exposure 8:32 a.m. May 8, 2014 - GlobeNewswire
TG Therapeutics, Inc. to Present at the 39th Annual Deutsche Bank Healthcare Conference 8:32 a.m. May 5, 2014 - GlobeNewswire
TG Therapeutics, Inc. Announces Preclinical Poster Presentations for TGR-1202 at AACR 2014 8:32 a.m. April 7, 2014 - GlobeNewswire
TG Therapeutics, Inc. Announces $18.1 Million Underwritten Sale of Common Stock to a Single Institutional Investor 5:13 p.m. March 11, 2014 - GlobeNewswire
TG Therapeutics, Inc. to Present at the 26th Annual ROTH Conference 10:01 a.m. March 10, 2014 - GlobeNewswire
TG Therapeutics, Inc. Announces Fourth Quarter and Year-End 2013 Financial Results and Business Update 5:07 p.m. March 5, 2014 - GlobeNewswire
TG Therapeutics, Inc. to Host Conference Call on Fourth Quarter and Year-End 2013 Financial Results and Business Update 9:31 a.m. March 4, 2014 - GlobeNewswire

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Endava Facing Securities Fraud Suit; Stocks Down 24%

Updated Category News Views 24

Endava Hits Rough Patch with Legal Battle Brewing So here we are, watching Endava plc struggle through legal quagmires and tumbling stock prices. Come September 21, 2026, news hit the street: Endava's CFO, Mark Thurston, found himself on administrative leave due to an investigation surrounding some shaky accounting practices. The Audit Committee raised a red flag, and...

Continue Reading
JobPlanner Boosts Tools to Shield Margins in Construction

Updated Category News Views 19

Real-Time Solutions for Real-World Challenges JobPlanner is stepping up its game with some beefed-up financial management tools, and I gotta admit, it's like a lifeline in the raging sea of construction costs. We're talking about a souped-up Real-Time Job Costing Suite tailored for general and specialty contractors who are tired of watching their profits evaporate into...

Continue Reading
Chicken Salad Chick Spices Up Holidays With Mary Mistletoe

Updated Category News Views 43

Dishing Out Holiday Spirit by the Scoop The holiday season's rolling around, and Chicken Salad Chick, this fast-casual joint that's got a bit of a thing for chicken salad, isn't letting the festive season pass by without a splash. They've brought out Mary Mistletoe, a holiday-themed chicken salad offering that just might become your table's centerpiece. "We wanted Mary...

Continue Reading
Martin's Holiday Heatwave: Mixing Summer Flavors

Updated Category News Views 45

Holiday Heatwave Meets Winter Cheer with Martin's Rolls Hold onto your oven mitts, folks, because Martin’s Famous Potato Rolls and Bread is stirring up the winter doldrums with an unexpected twist this holiday season. Forget the old cranberry sauce routine—it’s all about mixing sunny vibes with frosty festivities in their "Very Merry Martin’s: Holiday Heatwave."...

Continue Reading
Atrium's Heart Therapies: ATR 1072's Promising Data

Updated Category News Views 103

Atrium Therapeutics Strikes a Chord with New Data Tuning into the heartbeats of breakthrough developments, Atrium Therapeutics dropped some fresh, nonclinical insights about their latest contender, ATR 1072. This wasn't just any ordinary announcement; it's like when the market hears whispers of a Fed rate adjustment. The venue? The American Heart Association's 2026...

Continue Reading
Target Hospitality Readies for Q3 2026 Earnings Reveal

Updated Category News Views 51

The Thrill of Earnings Season Every trader worth their salt gets a tingle down the spine come earnings season. There's nothing quite like it—the build-up, the anticipation, the potential payouts. This time, we're zeroing in on Target Hospitality, bearing the ticker NASDAQ: TH. Come November 9, 2026, they're set to unveil what the past quarter had up its sleeve, and like...

Continue Reading
New Paths Emerge in Thin Film Dewetting Control

Updated Category News Views 83

The Thin Film Challenge: Decoding Dewetting Ah, dewetting—it's a bit like trying to keep a chocolate bar solid on a scorching summer day. These thin films, they're supposed to hold their own, spread thin and steady. But apply a little heat or a laser, and watch them form tiny islands, like a retreating tide. Now, there's some fresh thinking in the air, straight from...

Continue Reading
FirstEnergy Foundation Aims High with New Leadership

Updated Category News Views 0

Changing the Guard at FirstEnergy Foundation For a company with a hefty footprint across the northeastern United States, FirstEnergy Corp. (NYSE: FE) seems to be diving deep into the philanthropic pool with its recent leadership shuffle. Don Rettig, an experienced figure in the world of corporate philanthropy, is taking the helm as Vice President and President of the...

Continue Reading
Ebix and intentyx Tackle AI Security in Regulated Fields

Updated Category News Views 115

Ebix Aims to Rein in AI Mischief When you throw AI agents into the mix of regulated businesses like insurers, banks, and healthcare outfits, you get a storm brewing. Now, Ebix and intentyx seem to be donning their capes, aiming to bring clarity with their new SMARE security platform. Fancy name notwithstanding, this isn't about mind games—it's about real, observable...

Continue Reading
Harel Insurance Preps Q3 2026 Earnings Report

Updated Category News Views 96

Harel's Financial Spotlight: Next Moves on November 23, 2026 Harel Insurance Investments, a bigwig in the Israeli insurance landscape, is about to pull back the curtain on its third quarter 2026 financial report. Come November 23, the numbers will hit the streets, and every investor's gotta be asking: what's the latest play from Harel? Exploring Harel's Strategic...

Continue Reading

Top 5 Most Recently Viewed Articles

Market Watch: Stocks React to Labor Data and Earnings Reports

Updated Category News Views 76

Recent Market Activity Overview Recently, the US stock market displayed mixed results as investors digested labor market data that fell short of expectations. This information can significantly influence perceptions regarding potential interest rate changes and the overall state of the economy. Market Trends Explained The S&P 500 saw a slight decline, while the Dow Jones...

Continue Reading
Old National Bancorp to Showcase at Upcoming Financial Events

Updated Category News Views 188

Old National Bancorp's Upcoming Presentations Old National Bancorp (NASDAQ: ONB), a leading financial institution, is poised to participate in significant financial conferences that offer insights into the banking industry. Jim Ryan, the Chairman and Chief Executive Officer, will take the stage at the Raymond James & Associates 46th Annual Institutional Investors...

Continue Reading
AlphaGen Intelligence Strengthens Capital Structure through Debt Settlement

Updated Category News Views 169

AlphaGen Intelligence Strengthens Financial Position AlphaGen Intelligence Corp. (CSE: AIC | OTC: APETF | FSE: W4V), a forward-thinking company in the gaming and technology sector, has taken a significant step towards enhancing its financial position. By issuing over 2.25 million common shares to settle outstanding debts, the Company is implementing a strategic initiative...

Continue Reading
Red Canary Reports Strong Growth and Product Innovations

Updated Category News Views 420

Red Canary Reports Strong Growth and Product Innovations Rapid adoption of identity and cloud security protection is delivering greater customer value and fueling company growth. AI-driven workflows are enabling security teams to investigate threats 10x faster on average, delivering greater efficiency and security outcomes. Red Canary, a leader in managed detection and...

Continue Reading
Innovative Partnerships in Retina Care: AllyGPO and BioCareSD

Updated Category News Views 150

Transforming Retina Care Through Collaboration In a remarkable development, AllyGPO and BioCareSD have showcased their commitment to enhancing healthcare delivery with the recent partnership with Retina Associates of Cleveland, Inc (RACI). This strategic move speaks volumes about the evolving landscape of healthcare as it emphasizes a growing need for transparent and...

Continue Reading